检索结果-南通市图书馆

Effect of anti-VEGF treatment on retinopathy of prematurity in Zone Ⅱ Stage 3^+

International Journal of Ophthalmology(English edition) 2018年第4期11卷 641-644页

作者： Xiu-Mei Yang Yue-Xiang Zhao Zong-Hua Wang Lu Liu Department of Ophthalmology PLA Army General Hospital Department of Cardiology Nanlou Clinical Division of Chinese PLA General Hospital

AIM： To evaluate the effect of intravitreal ranibizumab injection for retinopathy of prematurity（ROP） in Zone Ⅱ Stage 3^＋.METHODS： Data was collected for ROP patients with Zone Ⅱ Stage 3^＋ who received intravitreal ranibizumab injections between October 2014 and Janu ary 2017 at the Department of Ophthalmology in our hospital. No prior laser or other intravitreal treatment was done. Prior to the intervention and at each follow-up visit, fundus examination was performed. Gestational age at birth, sex, birth weight, ROP zone, ROP stage, post menstrual age（PMA） at treatment, and follow-up pe riod were recorded. The final clinical status of the retina was evaluated for each patient. The primary outcome mea sures included ROP recurrences requiring re-treatment, complete or incomplete peripheral ***： Eighty-six eyes of 46 premature infants with Zone Ⅱ Stage 3~＋ ROP were enrolled in the study. The mean gestational age at birth was 28.18±1.67（range： 25 to 33）wk and the mean birth weight was 1070.57±226.85（range： 720.00 to 1650.00） g. The mean PMA at treatment was 38.32±2.99（range： 32.29 to 46.00）wk. Seventy-one eyes（82.56%） were treated success fully with intravitreal ranibizumab as monotherapy. Fifteen eyes（17.44%） developed recurrent disease. The mean interval between the treatment and retreatment was 5.96±3.22（range： 1.86 to 11.71）wk. All eyes vascularized into zone Ⅲ at the end of the study and among them 62 eyes（72.09%） achieved complete vascu ***： Intravitreal ranibizumab injection is an effective treatment in Zone Ⅱ Stage 3^＋ ROP patients. More patients with longer follow-up duration are necessary to confirm the safety and efficacy of this treatment.

关键词： retinopathy of prematurity ranibizumab plus disease

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：